ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Nephro Care India closes its Salt Lake, Kolkata dialysis unit from September 15, 2026 due to licensing constraints. Operations cease and premises will be vacated.
Nephro Care India Limited submitted its Annual Report for FY 2025-26 and the Notice for its 12th Annual General Meeting scheduled for September 25, 2026.
Nephro Care India Limited submitted its Statement of Deviation or Variation regarding IPO issue proceeds for the quarter ending June 30, 2026, confirming no deviations.
Nephro Care India Ltd reported revenue from operations of ₹29.2 Cr (+9.4% YoY) and net profit of ₹1.6 Cr (+60.0% YoY) for Q1 FY27.
Nephro Care India Limited informs that SEBI corporate governance regulations do not apply to it for Q June 2026. The filing records this compliance exemption.
Nephro Care submitted revised half‑yearly audited financial results, reporting total income of ₹2,674.63 crore. The filing addresses the exchange’s clarification request.
Nephro Care India confirmed the utilization of ₹33.72 Crore from IPO proceeds through March 2026. Funds were deployed for hospital setup and corporate purposes.
Nephro Care India Limited disclosed related party transactions for the half year ended March 31, 2026. The filing complies with SEBI's routine regulatory disclosure requirements.
Nephro Care India Ltd reported revenue from operations of ₹26.7 Cr and net profit of ₹1 Cr for Q4 FY26.
Nephro Care India Limited reported audited standalone total income of ₹90.28 Crore for FY26. The board approved unmodified financial results, signaling stable operational performance and transparency.
Nephro Care India Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the quarter ended March 31, 2026. The certificate, issued by Saptasikha & Co., confirms the company maintained a non-tamperable database for capturing UPSI events in compliance with SEBI (Prohibition of Insider Trading) Regulations.
Nephro Care India Limited informed the exchange that Corporate Governance provisions under Regulation 27(2) of SEBI LODR are not applicable to it. As an SME-listed entity on the NSE EMERGE platform, the company is exempt from these requirements for the quarter and year ended March 31, 2026.